Concepedia

Publication | Open Access

Hyperprogressive disease (HPD) is frequent in non-small cell lung cancer (NSCLC) patients (pts) treated with anti PD1/PD-L1 monoclonal antibodies (IO)

DOIFull Paper Access

28

Citations

0

References

2017

Year

Roberto Ferrara, Caroline Caramella, Matthieu Texier, Clarisse Audigier-Valette, Laurent Tessonnier, Laura Mezquita, J. Lahmar, Julien Mazières, Gérard Zalcman, Solenn Brosseau,
Annals of Oncology

No additional data available for this publication yet. Check back later!